| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.906 | 0.001 | 0.906 | Melatonin 2 agonist | |||
| 0.874 | 0.002 | 0.874 | Alcohol oxidase inhibitor | |||
| 0.833 | 0.002 | 0.833 | Alpha-N-acetylglucosaminidase inhibitor | 0.202 0.033 CID_107650 | ||
| 0.811 | 0.004 | 0.811 | Aldehyde oxidase inhibitor | |||
| 0.702 | 0.002 | 0.702 | Melatonin antagonist | |||
| 0.661 | 0.005 | 0.661 | Superoxide dismutase inhibitor | 0.425 0.023 CID_107650 | ||
| 0.644 | 0.003 | 0.644 | Porphobilinogen synthase inhibitor | |||
| 0.631 | 0.002 | 0.631 | Melatonin 1 antagonist | |||
| 0.559 | 0.002 | 0.559 | Ferrochelatase inhibitor | |||
| 0.554 | 0.001 | 0.554 | Thioredoxin reductase inhibitor | |||
| 0.526 | 0.002 | 0.526 | Creatine kinase inhibitor | |||
| 0.537 | 0.017 | 0.537 | GABA C receptor rho-3 antagonist | |||
| 0.487 | 0.003 | 0.487 | Aminoacyl-tRNA synthetase inhibitor | 0.186 0.012 CID_107650 | ||
| 0.481 | 0.003 | 0.481 | Succinate dehydrogenase inhibitor | 0.142 0.129 CID_107650 | ||
| 0.463 | 0.003 | 0.463 | Triose-phosphate isomerase inhibitor | |||
| 0.433 | 0.003 | 0.433 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.271 0.008 CID_107650 | ||
| 0.437 | 0.01 | 0.437 | Tubulin antagonist | |||
| 0.47 | 0.049 | 0.47 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.445 | 0.037 | 0.445 | 5 Hydroxytryptamine release stimulant | |||
| 0.381 | 0.004 | 0.381 | Adenylate kinase inhibitor | 0.322 0.006 CID_107650 | ||
| 0.379 | 0.011 | 0.379 | Tyrosine 3 hydroxylase inhibitor | 0.29 0.038 CID_107650 | ||
| 0.36 | 0.007 | 0.36 | Aldehyde dehydrogenase inhibitor | 0.241 0.02 CID_107650 | ||
| 0.355 | 0.003 | 0.355 | Melatonin agonist | |||
| 0.348 | 0.005 | 0.427 | Glutamate dehydrogenase inhibitor | 0.427 0.004 CID_107650 | CID_107650 | |
| 0.36 | 0.023 | 0.36 | 5 Hydroxytryptamine uptake stimulant | 0.199 0.153 CID_107650 | ||
| 0.36 | 0.027 | 0.745 | Peroxidase inhibitor | 0.745 0.002 CID_107650 | CID_107650 | |
| 0.33 | 0.008 | 0.33 | Cystathionine beta-synthase inhibitor | |||
| 0.326 | 0.003 | 0.326 | Biliverdin reductase inhibitor | |||
| 0.335 | 0.014 | 0.335 | Amylase inhibitor | |||
| 0.398 | 0.079 | 0.398 | 5 Hydroxytryptamine release inhibitor | |||
| 0.346 | 0.042 | 0.346 | DNA damaging | |||
| 0.306 | 0.009 | 0.306 | GABA C receptor agonist | 0.12 0.049 CID_107650 | ||
| 0.342 | 0.055 | 0.342 | Calcium channel activator | |||
| 0.294 | 0.01 | 0.294 | UDP-glucose 4-epimerase inhibitor | |||
| 0.391 | 0.118 | 0.391 | Apoptosis agonist | |||
| 0.276 | 0.007 | 0.389 | Catalase inhibitor | 0.389 0.004 CID_107650 | CID_107650 | |
| 0.305 | 0.042 | 0.305 | Antimitotic | |||
| 0.256 | 0.003 | 0.256 | Acyl-CoA dehydrogenase inhibitor | 0.135 0.011 CID_107650 | ||
| 0.254 | 0.007 | 0.254 | Alcohol dehydrogenase inhibitor | 0.112 0.041 CID_107650 | ||
| 0.251 | 0.004 | 0.251 | Cathepsin B inhibitor | 0.095 0.018 CID_107650 | ||
| 0.247 | 0.003 | 0.247 | Fumarate hydratase inhibitor | |||
| 0.252 | 0.013 | 0.252 | Cathepsin H inhibitor | 0.13 0.063 CID_107650 | ||
| 0.254 | 0.016 | 0.254 | Hexokinase inhibitor | |||
| 0.247 | 0.013 | 0.553 | Aminopeptidase B inhibitor | 0.553 0.003 CID_107650 | CID_107650 | |
| 0.226 | 0.003 | 0.226 | Melatonin 1 agonist | |||
| 0.249 | 0.026 | 0.249 | Histone acetyltransferase inhibitor | |||
| 0.228 | 0.009 | 0.558 | Mucolytic | 0.558 0.002 CID_107650 | CID_107650 | |
| 0.239 | 0.022 | 0.239 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.244 | 0.036 | 0.244 | Nitric-oxide synthase stimulant | |||
| 0.21 | 0.006 | 0.301 | Aminopeptidase I inhibitor | 0.301 0.003 CID_107650 | CID_107650 | |
| 0.221 | 0.017 | 0.579 | Expectorant | 0.579 0.003 CID_107650 | CID_107650 | |
| 0.233 | 0.031 | 0.233 | Lipid peroxidase inhibitor | 0.137 0.078 CID_107650 | ||
| 0.217 | 0.016 | 0.217 | Microtubule formation inhibitor | |||
| 0.346 | 0.149 | 0.346 | Caspase 9 stimulant | |||
| 0.256 | 0.059 | 0.268 | Calpain inhibitor | 0.268 0.049 CID_107650 | CID_107650 | |
| 0.216 | 0.022 | 0.216 | GABA C receptor rho-2 antagonist | |||
| 0.2 | 0.007 | 0.347 | Ornithine carbamoyltransferase inhibitor | 0.347 0.004 CID_107650 | CID_107650 | |
| 0.289 | 0.099 | 0.289 | Cholesterol antagonist | |||
| 0.183 | 0.002 | 0.183 | Dipeptidyl peptidase I inhibitor | |||
| 0.185 | 0.007 | 0.185 | Histamine N-methyltransferase inhibitor | |||
| 0.192 | 0.014 | 0.192 | GABA C receptor antagonist | |||
| 0.281 | 0.106 | 0.352 | Transcription factor NF kappa B inhibitor | 0.352 0.076 CID_107650 | CID_107650 | |
| 0.251 | 0.076 | 0.251 | Hypoglycemic | 0.199 0.113 CID_107650 | ||
| 0.243 | 0.071 | 0.244 | DNA synthesis inhibitor | 0.244 0.07 CID_107650 | CID_107650 | |
| 0.197 | 0.027 | 0.212 | Alkylator | 0.212 0.023 CID_107650 | CID_107650 | |
| 0.178 | 0.008 | 0.178 | Ca2+-transporting ATPase inhibitor | |||
| 0.199 | 0.034 | 0.199 | Arachidonic acid antagonist | |||
| 0.173 | 0.013 | 0.173 | NADH dehydrogenase inhibitor | |||
| 0.226 | 0.068 | 0.226 | RNA-directed DNA polymerase inhibitor | |||
| 0.165 | 0.016 | 0.165 | GABA C receptor rho-1 antagonist | |||
| 0.147 | 0.004 | 0.147 | Alpha-mannosidase inhibitor | 0.054 0.037 CID_107650 | ||
| 0.155 | 0.017 | 0.155 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.155 | 0.019 | 0.155 | DOPA decarboxylase inhibitor | |||
| 0.146 | 0.012 | 0.146 | Ornithine decarboxylase inhibitor | 0.109 0.035 CID_107650 | ||
| 0.183 | 0.05 | 0.183 | Acetylcholine M1 receptor antagonist | |||
| 0.136 | 0.004 | 0.136 | Catechol O-methyltransferase inhibitor | |||
| 0.135 | 0.004 | 0.135 | Mannosidase inhibitor | |||
| 0.176 | 0.045 | 0.176 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.148 | 0.018 | 0.148 | Phosphofructokinase-1 inhibitor | 0.097 0.033 CID_107650 | ||
| 0.167 | 0.038 | 0.167 | Adenylate cyclase stimulant | 0.15 0.063 CID_107650 | ||
| 0.152 | 0.022 | 0.152 | Urease inhibitor | |||
| 0.141 | 0.012 | 0.161 | Carbamoyl phosphate synthetase inhibitor | 0.161 0.01 CID_107650 | CID_107650 | |
| 0.182 | 0.053 | 0.371 | Phospholipase A2 inhibitor | 0.371 0.006 CID_107650 | CID_107650 | |
| 0.147 | 0.02 | 0.147 | Electrolyte absorption antagonist | |||
| 0.144 | 0.024 | 0.144 | Androgen antagonist | |||
| 0.259 | 0.148 | 0.527 | Histamine release inhibitor | 0.527 0.021 CID_107650 | CID_107650 | |
| 0.213 | 0.109 | 0.364 | Interleukin agonist | 0.364 0.025 CID_107650 | CID_107650 | |
| 0.107 | 0.004 | 0.107 | Ryanodine receptor antagonist | |||
| 0.117 | 0.016 | 0.122 | Argininosuccinate synthase inhibitor | 0.122 0.015 CID_107650 | CID_107650 | |
| 0.118 | 0.017 | 0.118 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.242 | 0.143 | 0.242 | Vasodilator, coronary | |||
| 0.113 | 0.014 | 0.113 | Cathepsin D inhibitor | 0.079 0.025 CID_107650 | ||
| 0.112 | 0.014 | 0.112 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.113 | 0.015 | 0.113 | Glycine receptor agonist | |||
| 0.11 | 0.012 | 0.11 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.185 | 0.087 | 0.185 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.129 | 0.032 | 0.129 | Anabolic | 0.119 0.041 CID_107650 | ||
| 0.137 | 0.04 | 0.137 | Photosensitizer | |||
| 0.117 | 0.022 | 0.818 | Glutamate decarboxylase inhibitor | 0.818 0.002 CID_107650 | CID_107650 | |
| 0.097 | 0.004 | 0.097 | Geranyltranstransferase inhibitor | |||
| 0.169 | 0.075 | 0.169 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.114 | 0.022 | 0.114 | Glycine receptor antagonist | |||
| 0.184 | 0.094 | 0.184 | Neurotrophic factor enhancer | |||
| 0.096 | 0.007 | 0.096 | Phosphoglycerate kinase inhibitor | |||
| 0.122 | 0.037 | 0.122 | Prolactin inhibitor | |||
| 0.106 | 0.021 | 0.106 | Amidase inhibitor | |||
| 0.125 | 0.043 | 0.125 | Carbonic anhydrase XV inhibitor | |||
| 0.084 | 0.002 | 0.084 | DNA polymerase III polC-type inhibitor | |||
| 0.095 | 0.014 | 0.095 | Glutamate (mGluR7) antagonist | |||
| 0.104 | 0.025 | 0.104 | D-Ala-D-Ala ligase inhibitor | |||
| 0.088 | 0.011 | 0.088 | Aconitate hydratase inhibitor | |||
| 0.084 | 0.008 | 0.084 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.091 | 0.015 | 0.091 | Glutamate (mGluR6) antagonist | 0.086 0.018 CID_107650 | ||
| 0.1 | 0.025 | 0.1 | Estrogen-related receptor beta agonist | |||
| 0.083 | 0.008 | 0.083 | Adenosine deaminase inhibitor | 0.057 0.024 CID_107650 | ||
| 0.169 | 0.095 | 0.169 | Anesthetic general | |||
| 0.077 | 0.004 | 0.077 | Uridine phosphorylase inhibitor | |||
| 0.208 | 0.136 | 0.306 | Gastrin inhibitor | 0.306 0.029 CID_107650 | CID_107650 | |
| 0.101 | 0.029 | 0.101 | Purinergic P2X2 antagonist | |||
| 0.097 | 0.027 | 0.176 | Phenylalanine 4-hydroxylase inhibitor | 0.176 0.009 CID_107650 | CID_107650 | |
| 0.211 | 0.141 | 0.427 | Insulysin inhibitor | 0.427 0.018 CID_107650 | CID_107650 | |
| 0.149 | 0.079 | 0.149 | Interferon gamma antagonist | |||
| 0.122 | 0.054 | 0.122 | 5 Hydroxytryptamine 3A agonist | |||
| 0.086 | 0.018 | 0.086 | Exportin-1 inhibitor | |||
| 0.09 | 0.023 | 0.09 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.104 | 0.037 | 0.104 | Glutamate release inhibitor | |||
| 0.091 | 0.025 | 0.091 | Vanilloid 4 agonist | |||
| 0.075 | 0.009 | 0.107 | Thymidylate synthase inhibitor | 0.107 0.004 CID_107650 | CID_107650 | |
| 0.066 | 0.003 | 0.066 | DNA polymerase III inhibitor | |||
| 0.146 | 0.084 | 0.146 | CF transmembrane conductance regulator agonist | |||
| 0.094 | 0.035 | 0.094 | Keratolytic | |||
| 0.092 | 0.033 | 0.092 | GABA aminotransferase inhibitor | |||
| 0.081 | 0.024 | 0.081 | Xanthine dehydrogenase inhibitor | |||
| 0.155 | 0.097 | 0.613 | Phospholipase C inhibitor | 0.613 0.004 CID_107650 | CID_107650 | |
| 0.081 | 0.024 | 0.081 | Purinergic P2X1 antagonist | |||
| 0.06 | 0.007 | 0.06 | Kainate receptor agonist | 0.047 0.017 CID_107650 | ||
| 0.067 | 0.014 | 0.067 | 5-Alpha-reductase inhibitor | |||
| 0.137 | 0.085 | 0.137 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.126 | 0.075 | 0.185 | Vanilloid 1 agonist | 0.185 0.016 CID_107650 | CID_107650 | |
| 0.087 | 0.036 | 0.087 | Epoxide hydrolase inhibitor | |||
| 0.088 | 0.038 | 0.574 | Histidine decarboxylase inhibitor | 0.574 0.002 CID_107650 | CID_107650 | |
| 0.09 | 0.041 | 0.09 | Na+ K+ transporting ATPase inhibitor | |||
| 0.068 | 0.019 | 0.068 | Dihydroorotate oxidase inhibitor | |||
| 0.071 | 0.023 | 0.071 | Cannabinoid CB2 receptor antagonist | |||
| 0.089 | 0.042 | 0.089 | CYP2A6 inhibitor | |||
| 0.066 | 0.019 | 0.066 | Pregnane X receptor antagonist | |||
| 0.149 | 0.103 | 0.149 | ATPase inhibitor | |||
| 0.059 | 0.012 | 0.059 | Dopamine D5 agonist | |||
| 0.08 | 0.034 | 0.08 | Phospholipase D inhibitor | |||
| 0.126 | 0.081 | 0.126 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.082 | 0.04 | 0.082 | MAP kinase kinase 7 inhibitor | |||
| 0.054 | 0.011 | 0.054 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.051 | 0.009 | 0.051 | Dipeptidyl peptidase II inhibitor | 0.031 0.026 CID_107650 | ||
| 0.056 | 0.015 | 0.056 | Guanylate cyclase inhibitor | |||
| 0.054 | 0.014 | 0.054 | Dihydrofolate reductase inhibitor | |||
| 0.119 | 0.079 | 0.197 | Cyclooxygenase 3 inhibitor | 0.197 0.02 CID_107650 | CID_107650 | |
| 0.147 | 0.109 | 0.25 | Neurotensin receptor agonist | 0.25 0.021 CID_107650 | CID_107650 | |
| 0.062 | 0.024 | 0.062 | Phosphorylase inhibitor | 0.041 0.036 CID_107650 | ||
| 0.049 | 0.012 | 0.05 | Glutamate (mGluR8) agonist | 0.05 0.012 CID_107650 | CID_107650 | |
| 0.083 | 0.047 | 0.083 | Interferon agonist | |||
| 0.068 | 0.031 | 0.068 | Cathepsin L inhibitor | 0.068 0.031 CID_107650 | ||
| 0.097 | 0.061 | 0.097 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.07 | 0.035 | 0.07 | Interferon inducer | |||
| 0.064 | 0.03 | 0.064 | Aldose reductase inhibitor | |||
| 0.081 | 0.047 | 0.081 | Estrogen receptor alpha antagonist | |||
| 0.05 | 0.016 | 0.137 | Membrane dipeptidase inhibitor | 0.137 0.002 CID_107650 | CID_107650 | |
| 0.057 | 0.024 | 0.057 | Squalene epoxidase inhibitor | |||
| 0.136 | 0.103 | 0.136 | Melanin inhibitor | |||
| 0.06 | 0.029 | 0.06 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.083 | 0.053 | 0.083 | CC chemokine 5 receptor agonist | |||
| 0.058 | 0.028 | 0.058 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.053 | 0.023 | 0.053 | Adenylate cyclase 1 inhibitor | |||
| 0.056 | 0.026 | 0.056 | Potassium channel (Inward rectifier) activator | |||
| 0.186 | 0.156 | 0.186 | Lipoxygenase inhibitor | |||
| 0.048 | 0.018 | 0.048 | Alpha 1d adrenoreceptor agonist | |||
| 0.038 | 0.008 | 0.038 | Purinergic P2Y15 antagonist | |||
| 0.064 | 0.036 | 0.157 | Carbonic anhydrase stimulant | 0.157 0.01 CID_107650 | CID_107650 | |
| 0.053 | 0.025 | 0.053 | Potassium channel (ATP-sensitive) activator | |||
| 0.053 | 0.025 | 0.053 | Oleamide hydrolase inhibitor | |||
| 0.058 | 0.03 | 0.058 | Immunoglobulin Fc receptor antagonist | |||
| 0.055 | 0.028 | 0.077 | Lysophosphatidic acid 3 receptor antagonist | 0.077 0.01 CID_107650 | CID_107650 | |
| 0.034 | 0.007 | 0.034 | Complement factor 1r inhibitor | |||
| 0.069 | 0.042 | 0.069 | MDM2 inhibitor | |||
| 0.05 | 0.024 | 0.05 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.133 | 0.107 | 0.133 | Heat shock protein 70 antagonist | |||
| 0.104 | 0.079 | 0.104 | Acetylcholine release stimulant | |||
| 0.032 | 0.008 | 0.032 | Vanilloid 2 agonist | |||
| 0.056 | 0.032 | 0.056 | Dipeptidyl peptidase inhibitor | |||
| 0.084 | 0.06 | 0.084 | mTOR complex 2 inhibitor | |||
| 0.047 | 0.023 | 0.047 | Histamine H1 receptor agonist | |||
| 0.047 | 0.024 | 0.047 | Histamine H2 receptor agonist | |||
| 0.064 | 0.041 | 0.064 | Cannabinoid CB1 receptor antagonist | |||
| 0.057 | 0.035 | 0.057 | Sphingosine kinase 2 inhibitor | |||
| 0.094 | 0.073 | 0.094 | Glutamate (mGluR7) agonist | |||
| 0.178 | 0.157 | 0.178 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.105 | 0.084 | 0.105 | Acetylcholine muscarinic antagonist | |||
| 0.103 | 0.083 | 0.103 | Cholesterol synthesis inhibitor | |||
| 0.186 | 0.167 | 0.186 | Prostaglandin dehydrogenase inhibitor | |||
| 0.11 | 0.09 | 0.393 | Toll-Like receptor 2 antagonist | 0.393 0.003 CID_107650 | CID_107650 | |
| 0.116 | 0.097 | 0.116 | Protein kinase stimulant | |||
| 0.062 | 0.043 | 0.062 | NMDA receptor glycine site agonist | |||
| 0.025 | 0.005 | 0.025 | Carbonic anhydrase VIII inhibitor | |||
| 0.025 | 0.005 | 0.025 | Carbonic anhydrase X inhibitor | |||
| 0.067 | 0.048 | 0.067 | Acetylcholine M5 receptor agonist | |||
| 0.066 | 0.048 | 0.066 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.087 | 0.068 | 0.087 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.074 | 0.056 | 0.074 | GABA B receptor agonist | |||
| 0.03 | 0.012 | 0.03 | Nicotinic acid receptor 2 antagonist | |||
| 0.044 | 0.026 | 0.044 | Heme oxygenase inhibitor | |||
| 0.029 | 0.012 | 0.029 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.022 | 0.006 | 0.022 | Telomerase stimulant | |||
| 0.028 | 0.011 | 0.028 | Complement factor 1s inhibitor | |||
| 0.028 | 0.013 | 0.028 | Lysophosphatidic acid receptor 1 agonist | 0.026 0.015 CID_107650 | ||
| 0.076 | 0.061 | 0.076 | Platelet growth factor antagonist | |||
| 0.068 | 0.052 | 0.068 | Cannabinoid receptor antagonist | |||
| 0.106 | 0.091 | 0.106 | Transcription factor STAT6 inhibitor | |||
| 0.062 | 0.048 | 0.174 | Protease 3C (Human rhinovirus) inhibitor | 0.174 0.005 CID_107650 | CID_107650 | |
| 0.089 | 0.074 | 0.089 | Sphingomyelinase inhibitor | |||
| 0.031 | 0.017 | 0.031 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.043 | 0.029 | 0.07 | Oxytocin agonist | 0.07 0.009 CID_107650 | CID_107650 | |
| 0.029 | 0.015 | 0.029 | Hedgehog signaling activator | |||
| 0.062 | 0.049 | 0.062 | Transcription factor RelA inhibitor | |||
| 0.126 | 0.113 | 0.126 | Pregnane X receptor agonist | |||
| 0.041 | 0.028 | 0.041 | Thymidine kinase inhibitor | |||
| 0.021 | 0.008 | 0.021 | Methylmalonyl-CoA mutase inhibitor | 0.02 0.009 CID_107650 | ||
| 0.056 | 0.044 | 0.056 | Aromatase inhibitor | |||
| 0.029 | 0.017 | 0.029 | Estrogen-related receptor gamma antagonist | |||
| 0.016 | 0.004 | 0.016 | Melatonin 2 antagonist | |||
| 0.027 | 0.016 | 0.027 | Sodium/glucose cotransporter inhibitor | |||
| 0.017 | 0.007 | 0.017 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.027 | 0.017 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.017 | 0.007 | 0.017 | Melatonin receptor 1A antagonist | |||
| 0.02 | 0.01 | 0.02 | Antibiotic Anthracycline-like | |||
| 0.06 | 0.05 | 0.162 | Neutrophil collagenase inhibitor | 0.162 0.011 CID_107650 | CID_107650 | |
| 0.032 | 0.022 | 0.035 | Glutamate (mGluR3) agonist | 0.035 0.016 CID_107650 | CID_107650 | |
| 0.071 | 0.061 | 0.071 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.047 | 0.038 | 0.047 | Dopamine beta hydroxylase inhibitor | |||
| 0.022 | 0.012 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.028 | 0.02 | 0.028 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.068 | 0.059 | 0.112 | Metalloproteinase-9 inhibitor | 0.112 0.027 CID_107650 | CID_107650 | |
| 0.053 | 0.045 | 0.053 | Dopamine uptake inhibitor | |||
| 0.026 | 0.017 | 0.026 | Acid ceramidase inhibitor | |||
| 0.033 | 0.025 | 0.033 | Melatonin receptor 1A agonist | |||
| 0.042 | 0.035 | 0.066 | AICAR transformylase inhibitor | 0.066 0.011 CID_107650 | CID_107650 | |
| 0.023 | 0.016 | 0.023 | Isoleucine-tRNA ligase inhibitor | |||
| 0.026 | 0.019 | 0.026 | Thymidine phosphorylase inhibitor | |||
| 0.016 | 0.01 | 0.016 | Purinergic P2Y1 agonist | |||
| 0.014 | 0.008 | 0.014 | Carbonic anhydrase XI inhibitor | |||
| 0.022 | 0.016 | 0.022 | Glutamate (mGluR1a) agonist | 0.022 0.016 CID_107650 | ||
| 0.061 | 0.055 | 0.061 | Calcium channel P-type blocker | |||
| 0.027 | 0.021 | 0.027 | Glucosylceramidase stimulant | |||
| 0.07 | 0.065 | 0.07 | Potassium channel (Tandem pore domain) blocker | |||
| 0.057 | 0.052 | 0.151 | NMDA receptor agonist | 0.151 0.008 CID_107650 | CID_107650 | |
| 0.046 | 0.041 | 0.046 | Cytokine production stimulant | |||
| 0.02 | 0.016 | 0.02 | Neuraminidase (Influenza B) inhibitor | |||
| 0.088 | 0.084 | 0.105 | Falcipain 3 inhibitor | 0.105 0.065 CID_107650 | CID_107650 | |
| 0.036 | 0.033 | 0.036 | GABA uptake inhibitor | |||
| 0.02 | 0.016 | 0.02 | Retinoid X beta receptor antagonist | |||
| 0.013 | 0.01 | 0.013 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.008 | 0.005 | 0.008 | DNA topoisomerase III inhibitor | |||
| 0.035 | 0.032 | 0.035 | Potassium channel Kv1.1 blocker | |||
| 0.031 | 0.029 | 0.031 | Retinoid X alpha receptor agonist | |||
| 0.027 | 0.025 | 0.027 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.016 | 0.014 | 0.016 | Alpha 2a adrenoreceptor agonist | |||
| 0.033 | 0.031 | 0.033 | Glutamate (mGluR3) antagonist | |||
| 0.086 | 0.085 | 0.086 | Bile acid receptor antagonist | |||
| 0.019 | 0.018 | 0.019 | Imidazoline I1 receptor antagonist | |||
| 0.01 | 0.011 | 0.011 | Glutamate (mGluR6) agonist | 0.011 0.01 CID_107650 | CID_107650 | |
| 0.028 | 0.033 | 0.15 | Arginase inhibitor | 0.15 0.002 CID_107650 | CID_107650 | |
| 0.031 | 0.04 | 0.298 | Toll-Like receptor 2 agonist | 0.298 0.002 CID_107650 | CID_107650 | |
| 0.029 | 0.037 | 0.031 | Calpain 1 inhibitor | 0.031 0.03 CID_107650 | CID_107650 | |
| 0.033 | 0.042 | 0.101 | AMPA 4 receptor antagonist | 0.101 0.005 CID_107650 | CID_107650 | |
| 0.02 | 0.03 | 0.147 | Lysine carboxypeptidase inhibitor | 0.147 0.003 CID_107650 | CID_107650 | |
| 0.025 | 0.035 | 0.07 | Calcitonin receptor agonist | 0.07 0.013 CID_107650 | CID_107650 | |
| 0.108 | 0.119 | 0.242 | Cell wall synthesis inhibitor | 0.242 0.017 CID_107650 | CID_107650 | |
| 0.02 | 0.032 | 0.024 | Glutamate (mGluR1) agonist | 0.024 0.018 CID_107650 | CID_107650 | |
| 0.064 | 0.077 | 0.126 | Metalloproteinase-2 inhibitor | 0.126 0.026 CID_107650 | CID_107650 | |
| 0.011 | 0.024 | 0.067 | Aminopeptidase A inhibitor | 0.067 0.003 CID_107650 | CID_107650 | |
| 0.068 | 0.088 | 0.535 | Glutathione S-transferase inhibitor | 0.535 0.001 CID_107650 | CID_107650 | |
| 0.039 | 0.064 | 0.105 | Bombesin 2 receptor antagonist | 0.105 0.014 CID_107650 | CID_107650 | |
| 0.025 | 0.051 | 0.056 | Carboxypeptidase B inhibitor | 0.056 0.005 CID_107650 | CID_107650 | |
| 0.02 | 0.045 | 0.079 | Peptide deformylase inhibitor | 0.079 0.004 CID_107650 | CID_107650 | |
| 0.01 | 0.038 | 0.023 | Neurokinin 1 agonist | 0.023 0.012 CID_107650 | CID_107650 | |
| 0.053 | 0.08 | 0.063 | Histone deacetylase SIRT3 inhibitor | 0.063 0.04 CID_107650 | CID_107650 | |
| 0.038 | 0.068 | 0.08 | HCV NS3/NS4A protease inhibitor | 0.08 0.011 CID_107650 | CID_107650 | |
| 0.013 | 0.044 | 0.024 | Caspase 8 inhibitor | 0.024 0.008 CID_107650 | CID_107650 | |
| 0.021 | 0.053 | 0.074 | Methionyl aminopeptidase 1 inhibitor | 0.074 0.004 CID_107650 | CID_107650 | |
| 0.037 | 0.07 | 0.049 | Prolyl endopeptidase inhibitor | 0.049 0.038 CID_107650 | CID_107650 | |
| 0.007 | 0.045 | 0.045 | Ileal bile acid transport inhibitor | 0.045 0.004 CID_107650 | CID_107650 | |
| 0.051 | 0.089 | 0.074 | Cathepsin G inhibitor | 0.074 0.049 CID_107650 | CID_107650 | |
| 0.028 | 0.068 | 0.153 | Ribonucleoside-diphosphate reductase inhibitor | 0.153 0.011 CID_107650 | CID_107650 | |
| 0.028 | 0.068 | 0.15 | Ribonucleotide reductase inhibitor | 0.15 0.012 CID_107650 | CID_107650 | |
| 0.003 | 0.044 | 0.01 | Carboxypeptidase B2 inhibitor | 0.01 0.008 CID_107650 | CID_107650 | |
| 0.027 | 0.069 | 0.179 | Antimetabolite | 0.179 0.01 CID_107650 | CID_107650 | |
| 0.074 | 0.118 | 0.101 | Adenylate cyclase inhibitor | 0.101 0.084 CID_107650 | CID_107650 | |
| 0.037 | 0.085 | 0.075 | NMDA 2C receptor antagonist | 0.075 0.028 CID_107650 | CID_107650 | |
| 0.006 | 0.056 | 0.017 | Integrin alphaVbeta6 antagonist | 0.017 0.007 CID_107650 | CID_107650 | |
| 0.158 | 0.21 | 0.223 | Neuropeptide Y2 antagonist | 0.223 0.084 CID_107650 | CID_107650 | |
| 0.039 | 0.092 | 0.067 | Botulinum neurotoxin type A inhibitor | 0.067 0.028 CID_107650 | CID_107650 | |
| 0.013 | 0.069 | 0.035 | Endothelial nitric-oxide synthase inhibitor | 0.035 0.017 CID_107650 | CID_107650 | |
| 0.011 | 0.072 | 0.045 | AMPA 3 receptor antagonist | 0.045 0.011 CID_107650 | CID_107650 | |
| 0.101 | 0.165 | 0.302 | Thiol protease inhibitor | 0.302 0.019 CID_107650 | CID_107650 | |
| 0.121 | 0.186 | 0.64 | Immunostimulant | 0.64 0.013 CID_107650 | CID_107650 | |
| 0.016 | 0.082 | 0.065 | Kainate receptor antagonist | 0.065 0.014 CID_107650 | CID_107650 | |
| 0.035 | 0.105 | 0.063 | CD45 antagonist | 0.063 0.019 CID_107650 | CID_107650 | |
| 0.074 | 0.146 | 0.169 | Caspase 3 inhibitor | 0.169 0.017 CID_107650 | CID_107650 | |
| 0.019 | 0.096 | 0.072 | NMDA 2A receptor antagonist | 0.072 0.023 CID_107650 | CID_107650 | |
| 0.013 | 0.095 | 0.076 | Calcium-sensing receptor agonist | 0.076 0.004 CID_107650 | CID_107650 | |
| 0.094 | 0.176 | 0.207 | Psychostimulant | 0.207 0.076 CID_107650 | CID_107650 | |
| 0.176 | 0.261 | 0.336 | Antibacterial | 0.336 0.11 CID_107650 | CID_107650 | |
| 0.018 | 0.104 | 0.071 | Factor XIIIa inhibitor | 0.071 0.009 CID_107650 | CID_107650 | |
| 0.005 | 0.095 | 0.055 | AMPA 1 receptor antagonist | 0.055 0.01 CID_107650 | CID_107650 | |
| 0.063 | 0.153 | 0.149 | Interleukin 1 beta converting enzyme inhibitor | 0.149 0.017 CID_107650 | CID_107650 | |
| 0.063 | 0.157 | 0.186 | Proteasome inhibitor | 0.186 0.03 CID_107650 | CID_107650 | |
| 0.104 | 0.198 | 0.273 | Insulin sensitizer | 0.273 0.024 CID_107650 | CID_107650 | |
| 0.019 | 0.122 | 0.064 | Metalloproteinase-3 inhibitor | 0.064 0.022 CID_107650 | CID_107650 | |
| 0.147 | 0.256 | 0.404 | Antithrombotic | 0.404 0.048 CID_107650 | CID_107650 | |
| 0.048 | 0.157 | 0.329 | Inducible nitric-oxide synthase inhibitor | 0.329 0.004 CID_107650 | CID_107650 | |
| 0.041 | 0.155 | 0.119 | Monophenol monooxygenase inhibitor | 0.119 0.062 CID_107650 | CID_107650 | |
| 0.024 | 0.144 | 0.074 | Matrix metalloproteinase (membrane-type) inhibitor | 0.074 0.022 CID_107650 | CID_107650 | |
| 0.016 | 0.139 | 0.095 | Matrix metalloproteinase 1 inhibitor | 0.095 0.015 CID_107650 | CID_107650 | |
| 0.015 | 0.141 | 0.265 | Glycine transporter 2 inhibitor | 0.265 0.004 CID_107650 | CID_107650 | |
| 0.053 | 0.182 | 0.347 | Nitric-oxide synthase inhibitor | 0.347 0.004 CID_107650 | CID_107650 | |
| 0.057 | 0.192 | 0.115 | Beta amyloid protein antagonist | 0.115 0.072 CID_107650 | CID_107650 | |
| 0.025 | 0.17 | 0.166 | Matrix metalloproteinase inhibitor | 0.166 0.012 CID_107650 | CID_107650 | |
| 0.063 | 0.226 | 0.125 | Antibacterial (Helicobacter pylori) | 0.125 0.074 CID_107650 | CID_107650 | |
| 0.129 | 0.311 | 0.45 | Sodium/bile acid cotransporter inhibitor | 0.45 0.008 CID_107650 | CID_107650 | |
| 0.071 | 0.261 | 0.213 | DNA methyltransferase I inhibitor | 0.213 0.063 CID_107650 | CID_107650 | |
| 0.106 | 0.298 | 0.272 | Calpain 2 inhibitor | 0.272 0.134 CID_107650 | CID_107650 | |
| 0.073 | 0.274 | 0.364 | DNA methylase inhibitor | 0.364 0.015 CID_107650 | CID_107650 | |
| 0.06 | 0.273 | 0.171 | Diuretic | 0.171 0.06 CID_107650 | CID_107650 | |
| 0.069 | 0.302 | 0.178 | Hemostatic | 0.178 0.043 CID_107650 | CID_107650 | |
| 0.027 | 0.294 | 0.11 | Somatostatin 1 agonist | 0.11 0.028 CID_107650 | CID_107650 | |
| 0.023 | 0.296 | 0.074 | Carbonic anhydrase II stimulant | 0.074 0.012 CID_107650 | CID_107650 | |
| 0.002 | 0.301 | 0.026 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.026 0.005 CID_107650 | CID_107650 | |
| 0.017 | 0.32 | 0.035 | Calcium-independent phospholipase A2 inhibitor | 0.035 0.02 CID_107650 | CID_107650 | |
| 0.016 | 0.322 | 0.063 | Histone deacetylase inhibitor | 0.063 0.049 CID_107650 | CID_107650 | |
| 0.011 | 0.32 | 0.055 | Growth hormone release inhibitor | 0.055 0.018 CID_107650 | CID_107650 | |
| 0.018 | 0.375 | 0.071 | Elastase 1 inhibitor | 0.071 0.045 CID_107650 | CID_107650 | |
| 0.02 | 0.435 | 0.075 | Vanilloid 2 antagonist | 0.075 0.011 CID_107650 | CID_107650 | |
| 0.037 | 0.453 | 0.22 | Antiamyloidogenic | 0.22 0.086 CID_107650 | CID_107650 | |
| 0.007 | 0.459 | 0.07 | Carbonic anhydrase I stimulant | 0.07 0.009 CID_107650 | CID_107650 | |
| 0.002 | 0.541 | 0.034 | Aminopeptidase P inhibitor | 0.034 0.008 CID_107650 | CID_107650 | |
| 0.012 | 0.757 | 0.042 | Integrin alpha1beta1 antagonist | 0.042 0.016 CID_107650 | CID_107650 | |
| 0.009 | 0.808 | 0.032 | HCV polyprotein inhibitor | 0.032 0.031 CID_107650 | CID_107650 | |
| 0.003 | 0.884 | 0.064 | Collagenase inhibitor | 0.064 0.012 CID_107650 | CID_107650 | |
| 0.011 | 0.901 | 0.115 | Adenine nucleotide translocase inhibitor | 0.115 0.004 CID_107650 | CID_107650 | |
| 0.008 | 0.899 | 0.477 | Angiogenesis stimulant | 0.477 0.013 CID_107650 | CID_107650 | |
| 0.008 | 0.919 | 0.088 | Vanilloid agonist | 0.088 0.052 CID_107650 | CID_107650 | |
| 0.007 | 0.925 | 0.086 | Bombesin 1 receptor agonist | 0.086 0.023 CID_107650 | CID_107650 | |
| 0.04 | 0.969 | 0.328 | Peptidyltransferase inhibitor | 0.328 0.016 CID_107650 | CID_107650 | |
| 0.026 | 0.975 | 0.397 | Interleukin 2 agonist | 0.397 0.028 CID_107650 | CID_107650 | |
| 0.002 | 0.951 | 0.04 | Caspase 2 inhibitor | 0.04 0.016 CID_107650 | CID_107650 | |
| 0.001 | 0.951 | 0.017 | Carbonic anhydrase IV stimulant | 0.017 0.009 CID_107650 | CID_107650 | |
| 0.003 | 0.955 | 0.075 | Endothelin-converting enzyme inhibitor | 0.075 0.019 CID_107650 | CID_107650 | |
| 0.005 | 0.958 | 0.054 | Neurokinin 2 agonist | 0.054 0.016 CID_107650 | CID_107650 | |
| 0.017 | 0.977 | 0.404 | Growth hormone agonist | 0.404 0.015 CID_107650 | CID_107650 | |
| 0.005 | 0.97 | 0.055 | Cathepsin F inhibitor | 0.055 0.008 CID_107650 | CID_107650 | |
| 0.002 | 0.97 | 0.033 | AMPA receptor agonist | 0.033 0.028 CID_107650 | CID_107650 | |
| 0.004 | 0.974 | 0.345 | Anticoagulant | 0.345 0.022 CID_107650 | CID_107650 | |
| 0.015 | 0.985 | 0.169 | Factor V inhibitor | 0.169 0.011 CID_107650 | CID_107650 | |
| 0.004 | 0.975 | 0.117 | Sirtuin 1 inhibitor | 0.117 0.015 CID_107650 | CID_107650 | |
| 0.002 | 0.977 | 0.033 | Growth factor receptor-bound protein 2 antagonist | 0.033 0.028 CID_107650 | CID_107650 | |
| 0.001 | 0.977 | 0.019 | Angiotensin-converting enzyme 2 inhibitor | 0.019 0.011 CID_107650 | CID_107650 | |
| 0.005 | 0.984 | 0.09 | Chymotrypsin inhibitor | 0.09 0.044 CID_107650 | CID_107650 | |
| 0.004 | 0.984 | 0.063 | Cholecystokinin B agonist | 0.063 0.011 CID_107650 | CID_107650 | |
| 0.005 | 0.986 | 0.054 | Glutamate (mGluR8) antagonist | 0.054 0.007 CID_107650 | CID_107650 | |
| 0.006 | 0.989 | 0.059 | Kallikrein 1 inhibitor | 0.059 0.035 CID_107650 | CID_107650 | |
| 0.004 | 0.988 | 0.079 | Neuropeptide agonist | 0.079 0.032 CID_107650 | CID_107650 | |
| 0.002 | 0.987 | 0.172 | Angiotensin-converting enzyme inhibitor | 0.172 0.005 CID_107650 | CID_107650 | |
| 0.009 | 0.995 | 0.169 | Transcription factor NF kappa B stimulant | 0.169 0.013 CID_107650 | CID_107650 | |
| 0.002 | 0.989 | 0.098 | Aminopeptidase N inhibitor | 0.098 0.013 CID_107650 | CID_107650 | |
| 0.002 | 0.989 | 0.154 | Selectin antagonist | 0.154 0.017 CID_107650 | CID_107650 | |
| 0.002 | 0.99 | 0.039 | AMPA 2 receptor antagonist | 0.039 0.015 CID_107650 | CID_107650 | |
| 0.008 | 0.996 | 0.168 | Folate antagonist | 0.168 0.017 CID_107650 | CID_107650 | |
| 0.005 | 0.995 | 0.076 | Caspase 9 inhibitor | 0.076 0.026 CID_107650 | CID_107650 | |
| 0.003 | 0.993 | 0.118 | Aminopeptidase microsomal inhibitor | 0.118 0.013 CID_107650 | CID_107650 | |
| 0.003 | 0.993 | 0.078 | Neurotensin receptor antagonist | 0.078 0.019 CID_107650 | CID_107650 | |
| 0.005 | 0.996 | 0.065 | Cathepsin E inhibitor | 0.065 0.034 CID_107650 | CID_107650 | |
| 0.004 | 0.996 | 0.059 | Gonadotropin-releasing hormone receptor agonist | 0.059 0.042 CID_107650 | CID_107650 | |
| 0.004 | 0.995 | 0.135 | Nav1.4 sodium channel blocker | 0.135 0.041 CID_107650 | CID_107650 | |
| 0.004 | 0.996 | 0.351 | Hepatoprotectant | 0.351 0.019 CID_107650 | CID_107650 | |
| 0.003 | 0.996 | 0.416 | Platelet antagonist | 0.416 0.024 CID_107650 | CID_107650 | |
| 0.003 | 0.996 | 0.175 | Protease inhibitor | 0.175 0.02 CID_107650 | CID_107650 | |
| 0.002 | 0.995 | 0.055 | Plasminogen activator inhibitor | 0.055 0.043 CID_107650 | CID_107650 | |
| 0.003 | 0.996 | 0.062 | Human rhinovirus A protease inhibitor | 0.062 0.033 CID_107650 | CID_107650 | |
| 0.003 | 0.996 | 0.309 | Chelator | 0.309 0.01 CID_107650 | CID_107650 | |
| 0.002 | 0.995 | 0.053 | Bombesin antagonist | 0.053 0.026 CID_107650 | CID_107650 | |
| 0.001 | 0.995 | 0.041 | Cholecystokinin A antagonist | 0.041 0.024 CID_107650 | CID_107650 | |
| 0.001 | 0.995 | 0.034 | Cholecystokinin B antagonist | 0.034 0.018 CID_107650 | CID_107650 | |
| 0.002 | 0.995 | 0.062 | Opioid delta receptor antagonist | 0.062 0.045 CID_107650 | CID_107650 | |
| 0.002 | 0.996 | 0.053 | Macrophage elastase inhibitor | 0.053 0.022 CID_107650 | CID_107650 | |
| 0.002 | 0.996 | 0.119 | Factor XII inhibitor | 0.119 0.024 CID_107650 | CID_107650 | |
| 0.002 | 0.996 | 0.096 | Multidrug resistance-associated protein 1 inhibitor | 0.096 0.085 CID_107650 | CID_107650 | |
| 0.001 | 0.995 | 0.053 | Cholecystokinin antagonist | 0.053 0.023 CID_107650 | CID_107650 | |
| 0.002 | 0.997 | 0.169 | Vasodilator | 0.169 0.133 CID_107650 | CID_107650 | |
| 0.002 | 0.996 | 0.041 | VCAM-1 antagonist | 0.041 0.021 CID_107650 | CID_107650 | |
| 0.002 | 0.996 | 0.041 | VCAM antagonist | 0.041 0.021 CID_107650 | CID_107650 | |
| 0.001 | 0.995 | 0.197 | Leukotriene A4 hydrolase inhibitor | 0.197 0.004 CID_107650 | CID_107650 | |
| 0.002 | 0.996 | 0.138 | Protein-tyrosine phosphatase inhibitor | 0.138 0.092 CID_107650 | CID_107650 | |
| 0.002 | 0.996 | 0.042 | Plasmin inhibitor | 0.042 0.037 CID_107650 | CID_107650 | |
| 0.002 | 0.996 | 0.066 | Opioid mu receptor antagonist | 0.066 0.049 CID_107650 | CID_107650 | |
| 0.003 | 0.997 | 0.438 | Apoptosis antagonist | 0.438 0.03 CID_107650 | CID_107650 | |
| 0.002 | 0.996 | 0.087 | Opioid antagonist | 0.087 0.061 CID_107650 | CID_107650 | |
| 0.002 | 0.997 | 0.246 | Histone deacetylase SIRT1 inhibitor | 0.246 0.018 CID_107650 | CID_107650 | |
| 0.002 | 0.996 | 0.168 | Histone deacetylase class III inhibitor | 0.168 0.032 CID_107650 | CID_107650 | |
| 0.002 | 0.997 | 0.18 | Bone formation stimulant | 0.18 0.042 CID_107650 | CID_107650 | |
| 0.002 | 0.996 | 0.075 | Analgesic, opioid | 0.075 0.055 CID_107650 | CID_107650 | |
| 0.002 | 0.997 | 0.226 | Free radical scavenger | 0.226 0.08 CID_107650 | CID_107650 | |
| 0.001 | 0.996 | 0.073 | Kinesin-like protein 1 inhibitor | 0.073 0.012 CID_107650 | CID_107650 | |
| 0.001 | 0.996 | 0.073 | Kinesin antagonist | 0.073 0.012 CID_107650 | CID_107650 | |
| 0.001 | 0.996 | 0.029 | Histone deacetylase class IIa inhibitor | 0.029 0.024 CID_107650 | CID_107650 | |
| 0.002 | 0.996 | 0.105 | Erythropoietin receptor agonist | 0.105 0.01 CID_107650 | CID_107650 | |
| 0.001 | 0.996 | 0.035 | Histone deacetylase 5 inhibitor | 0.035 0.022 CID_107650 | CID_107650 | |
| 0.002 | 0.997 | 0.192 | Platelet adhesion inhibitor | 0.192 0.075 CID_107650 | CID_107650 | |
| 0.002 | 0.997 | 0.072 | Trypsin inhibitor | 0.072 0.032 CID_107650 | CID_107650 | |
| 0.002 | 0.997 | 0.493 | Hematopoietic | 0.493 0.004 CID_107650 | CID_107650 | |
| 0.001 | 0.996 | 0.09 | Complement C3a chemotactic receptor antagonist | 0.09 0.011 CID_107650 | CID_107650 | |
| 0.002 | 0.997 | 0.26 | Antioxidant | 0.26 0.079 CID_107650 | CID_107650 | |
| 0.001 | 0.996 | 0.069 | Neutral endopeptidase inhibitor | 0.069 0.005 CID_107650 | CID_107650 | |
| 0.001 | 0.996 | 0.02 | Integrin alphaVbeta3 antagonist | 0.02 0.018 CID_107650 | CID_107650 | |
| 0.001 | 0.996 | 0.113 | Glucagon-like peptide 1 agonist | 0.113 0.016 CID_107650 | CID_107650 | |
| 0.001 | 0.996 | 0.019 | Vitronectin receptor antagonist | 0.019 0.017 CID_107650 | CID_107650 | |
| 0.002 | 0.997 | 0.284 | Immunosuppressant | 0.284 0.126 CID_107650 | CID_107650 | |
| 0.001 | 0.996 | 0.051 | Renin inhibitor | 0.051 0.017 CID_107650 | CID_107650 | |
| 0.001 | 0.996 | 0.043 | Bradykinin B2 receptor agonist | 0.043 0.01 CID_107650 | CID_107650 | |
| 0.002 | 0.997 | 0.584 | Interleukin antagonist | 0.584 0.013 CID_107650 | CID_107650 | |
| 0.001 | 0.997 | 0.038 | Trypsin I inhibitor | 0.038 0.019 CID_107650 | CID_107650 | |
| 0.001 | 0.997 | 0.05 | Farnesyltransferase inhibitor | 0.05 0.028 CID_107650 | CID_107650 | |
| 0.001 | 0.997 | 0.095 | Thrombin inhibitor | 0.095 0.029 CID_107650 | CID_107650 | |
| 0.002 | 0.997 | 0.428 | Thrombolytic | 0.428 0.009 CID_107650 | CID_107650 | |
| 0.002 | 0.997 | 0.147 | Cell adhesion inhibitor | 0.147 0.048 CID_107650 | CID_107650 | |
| 0.001 | 0.997 | 0.096 | Nitric oxide donor | 0.096 0.01 CID_107650 | CID_107650 | |
| 0.001 | 0.997 | 0.035 | VLA-4 antagonist | 0.035 0.016 CID_107650 | CID_107650 | |
| 0.002 | 0.998 | 0.132 | Insulin secretagoues | 0.132 0.094 CID_107650 | CID_107650 | |
| 0.002 | 0.998 | 0.606 | Immunomodulator | 0.606 0.011 CID_107650 | CID_107650 | |
| 0.002 | 0.998 | 0.154 | Tumour necrosis factor alpha release inhibitor | 0.154 0.153 CID_107650 | CID_107650 | |
| 0.001 | 0.997 | 0.062 | Protocollagen prolyl hydroxylase inhibitor | 0.062 0.005 CID_107650 | CID_107650 | |
| 0.001 | 0.997 | 0.021 | Integrin alpha4 antagonist | 0.021 0.02 CID_107650 | CID_107650 | |
| 0.001 | 0.997 | 0.097 | Integrin antagonist | 0.097 0.017 CID_107650 | CID_107650 | |
| 0.001 | 0.997 | 0.018 | Tryptophan hydroxylase 1 inhibitor | 0.018 0.01 CID_107650 | CID_107650 | |
| 0.001 | 0.998 | 0.249 | Toll-Like receptor agonist | 0.249 0.149 CID_107650 | CID_107650 | |
| 0.001 | 0.997 | 0.064 | Integrin alpha5beta1 antagonist | 0.064 0.01 CID_107650 | CID_107650 | |
| 0.001 | 0.997 | 0.115 | GP IIb/IIIa receptor antagonist | 0.115 0.015 CID_107650 | CID_107650 | |
| 0.001 | 0.998 | 0.088 | Cell adhesion molecule inhibitor | 0.088 0.044 CID_107650 | CID_107650 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |